Literature DB >> 18796545

Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents.

June Zhou1, Roy J Martin, Richard T Tulley, Anne M Raggio, Kathleen L McCutcheon, Li Shen, Samuel Colby Danna, Sasmita Tripathy, Maren Hegsted, Michael J Keenan.   

Abstract

Glucagon-like peptide-1 (GLP-1) and peptide YY (PYY) are anti-diabetes/obesity hormones secreted from the gut after meal ingestion. We have shown that dietary-resistant starch (RS) increased GLP-1 and PYY secretion, but the mechanism remains unknown. RS is a fermentable fiber that lowers the glycemic index of the diet and liberates short-chain fatty acids (SCFAs) through fermentation in the gut. This study investigates the two possible mechanisms by which RS stimulates GLP-1 and PYY secretion: the effect of a meal or glycemic index, and the effect of fermentation. Because GLP-1 and PYY secretions are stimulated by nutrient availability in the gut, the timing of blood sample collections could influence the outcome when two diets with different glycemic indexes are compared. Thus we examined GLP-1 and PYY plasma levels at various time points over a 24-h period in RS-fed rats. In addition, we tested proglucagon (a precursor to GLP-1) and PYY gene expression patterns in specific areas of the gut of RS-fed rats and in an enteroendocrine cell line following exposure to SCFAs in vitro. Our findings are as follows. 1) RS stimulates GLP-1 and PYY secretion in a substantial day-long manner, independent of meal effect or changes in dietary glycemia. 2) Fermentation and the liberation of SCFAs in the lower gut are associated with increased proglucagon and PYY gene expression. 3) Glucose tolerance, an indicator of increased active forms of GLP-1 and PYY, was improved in RS-fed diabetic mice. We conclude that fermentation of RS is most likely the primary mechanism for increased endogenous secretions of total GLP-1 and PYY in rodents. Thus any factor that affects fermentation should be considered when dietary fermentable fiber is used to stimulate GLP-1 and PYY secretion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18796545      PMCID: PMC2584810          DOI: 10.1152/ajpendo.90637.2008

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  43 in total

1.  Dietary lactitol fermentation increases circulating peptide YY and glucagon-like peptide-1 in rats and humans.

Authors:  Jennifer M Gee; Ian T Johnson
Journal:  Nutrition       Date:  2005-10       Impact factor: 4.008

Review 2.  The therapeutic potential of gut hormone peptide YY3-36 in the treatment of obesity.

Authors:  Caroline J Small; Stephen R Bloom
Journal:  Expert Opin Investig Drugs       Date:  2005-05       Impact factor: 6.206

Review 3.  Dietary fibre, glycaemic response, and diabetes.

Authors:  Charles S Brennan
Journal:  Mol Nutr Food Res       Date:  2005-06       Impact factor: 5.914

4.  The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway.

Authors:  Caroline R Abbott; Mariana Monteiro; Caroline J Small; Arshia Sajedi; Kirsty L Smith; James R C Parkinson; Mohammad A Ghatei; Stephen R Bloom
Journal:  Brain Res       Date:  2005-04-07       Impact factor: 3.252

5.  Effect of large bowel fermentation on insulin, glucose, free fatty acids, and glucagon-like peptide 1 (7-36) amide in patients with coronary heart disease.

Authors:  G Frost; A Brynes; A Leeds
Journal:  Nutrition       Date:  1999-03       Impact factor: 4.008

6.  Involvement of endogenous glucagon-like peptide-1(7-36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats.

Authors:  Patrice D Cani; Catherine A Daubioul; Brigitte Reusens; Claude Remacle; Grégory Catillon; Nathalie M Delzenne
Journal:  J Endocrinol       Date:  2005-06       Impact factor: 4.286

7.  Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1.

Authors:  Patrice D Cani; Audrey M Neyrinck; Nicole Maton; Nathalie M Delzenne
Journal:  Obes Res       Date:  2005-06

8.  Impact of inulin and oligofructose on gastrointestinal peptides.

Authors:  Nathalie M Delzenne; Patrice D Cani; Catherine Daubioul; Audrey M Neyrinck
Journal:  Br J Nutr       Date:  2005-04       Impact factor: 3.718

9.  The importance of acclimatisation and habituation to experimental conditions when investigating the anorectic effects of gastrointestinal hormones in the rat.

Authors:  C R Abbott; C J Small; A Sajedi; K L Smith; J R C Parkinson; L L Broadhead; M A Ghatei; S R Bloom
Journal:  Int J Obes (Lond)       Date:  2006-02       Impact factor: 5.095

10.  Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin.

Authors:  Judith Korner; Marc Bessler; L J Cirilo; Irene M Conwell; Amna Daud; Nancy L Restuccia; Sharon L Wardlaw
Journal:  J Clin Endocrinol Metab       Date:  2004-10-13       Impact factor: 5.958

View more
  134 in total

1.  Dietary-resistant starch improves maternal glycemic control in Goto-Kakizaki rat.

Authors:  Li Shen; Michael J Keenan; Anne Raggio; Cathy Williams; Roy J Martin
Journal:  Mol Nutr Food Res       Date:  2011-06-03       Impact factor: 5.914

Review 2.  Diet: friend or foe of enteroendocrine cells--how it interacts with enteroendocrine cells.

Authors:  Sofia Moran-Ramos; Armando R Tovar; Nimbe Torres
Journal:  Adv Nutr       Date:  2012-01-05       Impact factor: 8.701

Review 3.  Improving healthspan via changes in gut microbiota and fermentation.

Authors:  Michael J Keenan; Maria L Marco; Donald K Ingram; Roy J Martin
Journal:  Age (Dordr)       Date:  2015-09-14

Review 4.  Satiety Innovations: Food Products to Assist Consumers with Weight Loss, Evidence on the Role of Satiety in Healthy Eating: Overview and In Vitro Approximation.

Authors:  Rubén López-Nicolás; Massimo Marzorati; Lia Scarabottolo; Jason C G Halford; Alexandra M Johnstone; Carmen Frontela-Saseta; Angel M Sanmartín; Gaspar Ros-Berruezo; Joanne A Harrold
Journal:  Curr Obes Rep       Date:  2016-03

5.  Dietary Fiber Protects against Diabetic Nephropathy through Short-Chain Fatty Acid-Mediated Activation of G Protein-Coupled Receptors GPR43 and GPR109A.

Authors:  Yan Jun Li; Xiaochen Chen; Tony K Kwan; Yik Wen Loh; Julian Singer; Yunzi Liu; Jin Ma; Jian Tan; Laurence Macia; Charles R Mackay; Steven J Chadban; Huiling Wu
Journal:  J Am Soc Nephrol       Date:  2020-05-01       Impact factor: 10.121

6.  Obese Mice Losing Weight Due to trans-10,cis-12 Conjugated Linoleic Acid Supplementation or Food Restriction Harbor Distinct Gut Microbiota.

Authors:  Laura J den Hartigh; Zhan Gao; Leela Goodspeed; Shari Wang; Arun K Das; Charles F Burant; Alan Chait; Martin J Blaser
Journal:  J Nutr       Date:  2018-04-01       Impact factor: 4.798

Review 7.  Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective.

Authors:  Jun-Ling Han; Hui-Ling Lin
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

Review 8.  Gut Microbiota in Obesity and Undernutrition.

Authors:  Nicolien C de Clercq; Albert K Groen; Johannes A Romijn; Max Nieuwdorp
Journal:  Adv Nutr       Date:  2016-11-15       Impact factor: 8.701

9.  Consumption of Cross-Linked Resistant Starch (RS4(XL)) on Glucose and Insulin Responses in Humans.

Authors:  Enas K Al-Tamimi; Paul A Seib; Brian S Snyder; Mark D Haub
Journal:  J Nutr Metab       Date:  2009-08-23

Review 10.  Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?

Authors:  Giovanni Musso; Roberto Gambino; Maurizio Cassader
Journal:  Diabetes Care       Date:  2010-10       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.